AI Summary & Key Takeaways
AI InsightIn our study, there is no difference between mild-moderate and severe groups in terms of maternal and perinatal outcomes.
📌 3 Key Takeaways
Abstract
Objective: COVID-19 has spread all over the world since December 2019. There is little evidence concerning maternal or perinatal outcomes up to now. The present study aimed to compare pregnant women with severe and mild-moderate COVID-19 symptoms in terms of maternal and perinatal outcomes. Methods: The study group was composed of pregnant patients admitted to our tertiary center with symptoms and diagnosed with severe acute respiratory syndrome Coronavirus 2 (SARS-Cov-2). The patients were categorized into two groups: severe and not severe, and women determined as in the severe disease group were hospitalized. The patients were continued to their routine follow-up, their maternal and perinatal outcomes were recorded. Results: A total of 52 patients were enrolled in the study: 59.6% presented mild-moderate disease and 40.4% presented severe disease. The gestational age at diagnosis of COVID-19 was higher in the patients with severe symptoms than in patients with mild-moderate symptoms (median 20.5 vs 28.0, respectively, p=0.048). There was no difference between those two groups in terms of maternal and perinatal outcomes. Conclusion: Despite the growing number of published studies on COVID-19 in pregnancy, there are insufficient quality data to draw conclusions about the severity of COVID-19 in symptomatic pregnant women and its maternal and neonatal consequences. In our study, there is no difference between mild-moderate and severe groups in terms of maternal and perinatal outcomes.
Özet
Amaç: Aral›k 2019’dan bu yana COVID-19 tüm dünyaya yay›ld›. fiu ana kadar maternal veya perinatal sonuçlarla ilgili olarak elimizde çok az kan›t bulunmaktad›r. Bu çal›flmada, fliddetli ve hafif-orta fliddette COVID-19 semptomlar› olan gebeleri maternal ve perinatal sonuçlar bak›m›ndan karfl›laflt›rmay› amaçlad›k. Yöntem: Çal›flma grubu, fliddetli akut respiratuvar sendrom Koronavirüs 2 (SARS-Cov-2) semptomlar›yla üçüncü basamak merkezimize baflvuran ve tan› alm›fl gebelerden olufltu. Hastalar fliddetli ve fliddetli olmayan fleklinde iki gruba ayr›ld› ve fliddetli hastal› k grubunda oldu¤una karar verilen gebeler hastaneye yat›r›ld›. Hastalar›n rutin takiplerine devam edilerek maternal ve perinatal sonuçlar› kaydedildi. Bulgular: Çal›flmaya toplam 52 hasta dahil edildi, bunlar›n %59.6’s›nda hafif-orta fliddette ve %40.4’ünde fliddetli hastal›k mevcuttu. COVID-19 tan›s› esnas›nda gestasyonel yafl, fliddetli semptomlar› olan hastalarda hafif-orta fliddette semptomu olan hastalardan daha yüksekti (s›ras›yla medyan: 20.5’e karfl› 28.0, p=0.048). Maternal ve perinatal sonuçlar yönünden bu iki grup aras›nda hiçbir fark yoktu. Sonuç: Gebelikte COVID-19 üzerine artan say›da yay›nlanm›fl çal›flmaya ra¤men, semptomatik gebelerde COVID-19’un fliddeti ve maternal ve neonatal sonuçlar› hakk›nda sonuç ç›karmaya yetecek miktarda kaliteli veri bulunmamaktad›r. Çal›flmam›zda, hafiforta fliddette semptomlu grup ile fliddetli semptomlu grup aras›nda maternal ve perinatal sonuçlar yönünden fark yoktu.